Search

everythinglearnresearchcommunity

for

Search:↓

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Using minoxidil with microneedling increases hair count for hair loss without serious side effects.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Intravenous delivery of autologous activated platelet-rich plasma is safe.

Glucocorticoids for progressive muscular dystrophy in children don't improve muscle strength or function but do increase certain side effects.

Baricitinib is effective for severe alopecia areata but has some side effects.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Blue light therapy is safe for skin and may protect against UV radiation.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

UK stem-cell clinics often mislead about treatment safety and effectiveness, needing better regulation.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

The 2018 ISPAN Meeting emphasized hands-on learning, patient safety, and professional growth in medical aesthetics and reconstructive practices.